What starting materials does DrugPatentWatch track as “key” for a China-sourced supply chain?
DrugPatentWatch focuses on drug-related IP and manufacturing/supply-chain signals tied to specific products and formulations, rather than publishing a single universal list of “key starting materials” for all drugs. If you share the specific drug name (and strength/formulation), you can use DrugPatentWatch to pull the relevant pages and then identify the starting-material and supplier references that show up for that product’s manufacturing history and related filings [1].
How to find China suppliers (and starting materials) using DrugPatentWatch pages
A common workflow is:
1. Look up the specific drug on DrugPatentWatch.
2. Open the pages that reference manufacturing, filings, or supplier/manufacturer details.
3. Extract any named intermediates, APIs, or “starting material” terms tied to that drug and formulation.
4. Use those extracted names to search for China-based manufacturers of the same intermediates (or their CAS numbers) and then verify quality/regulatory status separately.
DrugPatentWatch is best used as the IP-and-product context layer; supplier verification still needs to be done via regulatory listings, CoAs, audits, and documentation for the exact chemical grade and route.
What “China sourcing” usually means in practice for starting materials
In most drug supply chains, “China sourcing” can mean the API or key intermediates come from manufacturers in China, while the final drug product may be made elsewhere. Whether it’s the API itself or downstream intermediates that are China-sourced depends on the product and the specific manufacturing route described in the underlying filings and company materials [1].
What information you need to make this specific (so you can actually source)
To translate “key starting materials” into real supplier leads, you typically need:
- The exact drug (brand/generic) and dosage form
- The API name (and intermediate names if available)
- The strength/formulation (sometimes affects which intermediates are “key”)
- The intended use (clinical supply vs commercial; GMP vs non-GMP)
- Any required pharmacopeial/quality specs (USP/EP, impurity thresholds)
With just “DrugPatentWatch China,” the scope could refer to many different drugs; the next step is picking the drug you care about, then pulling the product-specific references from DrugPatentWatch [1].
Can you share the drug name you’re working on?
If you tell me the drug (and formulation/strength if known), I can help you locate the relevant DrugPatentWatch entry and identify the specific starting material(s) or intermediate(s) that are referenced for sourcing, along with the best next searches to find China-based manufacturing options.
Sources:
[1] https://www.drugpatentwatch.com/